SubjectWell Stock

SubjectWell is the risk-free clinical trials marketplace for patient recruitment

Sign up today and learn more about SubjectWell Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About SubjectWell Stock

SubjectWell is the risk-free clinical trials marketplace for patient recruitment

Funding History

February 2018$1.8M
June 2019$10.0M
October 2022$35.0M

Management

Chief Growth Officer

Joel Lucas

Board Of Directors

Enmi Kendall

CEO

Ivor Clarke

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo